Czech Republic: Proposed new medicinal product supply obligations and mandatory stock requirements

Draft amendment to the Act on Medicinal Products and the Act on Public Health Insurance

In brief

Draft amendment to the Act on Medicinal Products and the Act on Public Health Insurance


In depth

As many other countries in the EU, the Czech Republic has repeatedly experienced shortages in the supply of medicinal products for human use ("Medicinal Products"). In response to this unfavorable situation, the Government of the Czech Republic prepared and submitted for discussion to the Parliament of the Czech Republic a draft amendment to Act No. 378/2007 Sb. on Medicinal Products and on Changes to Some Related Acts, as amended ("Act on Medicinal Products"). This draft aims to implement new tools and obligations meant to improve the availability of Medicinal Products for patients in the Czech Republic, which will affect practically all links of the distribution chain. During the consideration process before the Chamber of Deputies of the Parliament of the Czech Republic, a number of legislative riders were introduced (such as the widely discussed comprehensive legislative rider originating with the Ministry of Health of the Czech Republic ("Ministry")), including the proposed amendments to Act No. 48/1997 Sb., on Public Health Insurance on Changes and Supplements to Some Related Acts, as amended ("Act on Public Health Insurance").

On 15 November 2023, the respective draft amendment to the Act on Medicinal Products and the Act on Public Health Insurance (including some of these legislative riders) ("Amendment") was approved by the Chamber of Deputies of the Parliament of the Czech Republic and will now be submitted to the Senate of the Parliament of the Czech Republic for discussion.

Although the legislative process for the Amendment has not been completed yet, and the Amendment wording cannot, therefore, be considered final, we would like to provide an overview of the proposed legislative changes most relevant for Medicinal Product distributors and marketing authorization holders (MAH).

Click here to access the full alert.

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.